Clinical Trials in Plymouth, UK | Priya Life Science

Clinical Trials in Plymouth

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Not yet open

A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

NCT07728188Relapsed or Refractory Multiple Myeloma

AbbVie

Phase 3

520

Plymouth, Edinburgh, London, Portsmouth, Airdrie, Nottingham

2026-11-30

Recruiting

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

NCT07227896Parkinson's Disease

AbbVie

Observational

100

Plymouth

2026-08-03

Active, closed

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

NCT06667687Non-Hodgkin's Lymphoma

AbbVie

Phase 1

Manchester, Plymouth

2025-01-16

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

NCT06461897Atopic Dermatitis

AbbVie

Phase 3

675

Plymouth, London, Southampton, Glasgow, Manchester, Newcastle upon Tyne

2024-08-19

Active, closed

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

NCT04862286Psoriasis

AbbVie

Phase 3

132

Exeter, Plymouth, London

2021-07-24

Active, closed

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

NCT04401748Myelodysplastic Syndrome (MDS)

AbbVie

Phase 3

531

Plymouth, Poole, London, Oxford, Cardiff, Aberdeen, Birmingham, Bristol

2020-09-10

Active, closed

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma

AbbVie

Phase 3

165

Plymouth, Leicester, London, Southampton, Blackpool, Liverpool, Wolverhampton

2019-09-06

Active, closed

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

NCT01848561Ulcerative Colitis (UC)

AbbVie

Observational

8,250

Warrington, Darlington, Plymouth, Poole, Hull, London, Basingstoke, Glasgow

2013-04-29

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 September 2026. https://priyalifescience.com/clinical-trials-uk/city/plymouth

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →